Confounders in Identification and Analysis of Inflammatory Biomarkers in Cardiovascular Diseases

Qurrat Ul Ain1, Mehak Sarfraz2, Gayuk Kalih Prasesti1

  • 1Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia.

Biomolecules
|October 23, 2021
PubMed

Insights

Systemic inflammation, measured by biomarkers like C-reactive protein (CRP) and interleukins (IL), is linked to cardiovascular disease. This review examines how demographic, lifestyle, and analytical factors affect these key inflammatory biomarker levels.

Area of Science:

  • Biomedical Science
  • Epidemiology
  • Immunology

Background:

  • Proinflammatory biomarkers are crucial for studying systemic inflammation and cardiovascular diseases (CVD).
  • While elevated inflammatory biomarkers correlate with CVD pathology, underlying mechanisms remain unclear.
  • Identifying biomarkers like cytokines, chemokines, and acute-phase proteins aids early disease diagnosis.

Purpose of the Study:

  • To review and summarize the impact of demographic, epidemiological, medication, and analytical factors on serum inflammatory biomarker concentrations.
  • To investigate variations in key biomarkers including C-reactive protein (CRP), Interleukin-1 beta (IL-1b), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNFa), and soluble TNF receptors.
  • To understand how confounding variables influence the measurement and interpretation of inflammatory biomarkers in research.

Main Methods:

  • Systematic review of studies investigating inflammatory biomarkers and CVD.
  • Analysis of factors influencing biomarker concentrations: age, sex, BMI, medication use, lifestyle, and medical history.
  • Examination of pre-analytical (sample collection, storage) and analytical (assay methods, data processing) variations.
  • Focus on specific biomarkers: CRP, IL-1b, IL-6, TNFa, and soluble TNF receptors.

Main Results:

  • Demographic factors (age, sex) and lifestyle (BMI, substance use) significantly influence biomarker levels.
  • Medication use and co-existing medical conditions introduce variability in inflammatory marker concentrations.
  • Pre-analytical and analytical inconsistencies can lead to significant variations in reported biomarker results.
  • Specific patterns of variation were observed for CRP, IL-1b, IL-6, TNFa, and soluble TNF receptors.

Conclusions:

  • Confounding factors, including demographic, epidemiological, and analytical variables, critically affect inflammatory biomarker concentrations.
  • Standardization of methodologies is essential to reduce variability and improve the reliability of biomarker studies in CVD research.
  • Further research is needed to elucidate the precise mechanisms linking inflammation and CVD, accounting for these influential factors.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
261
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
399
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
297
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
174
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
483
Inflammation01:38

Inflammation

Overview
56.2K